Atlas Trials

The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma

Clinical trial NCT05100368 · COMPLETED

Trial details

NCT number
NCT05100368
Sponsor
Istituto Ortopedico Rizzoli
Status
COMPLETED
Study type
OBSERVATIONAL
Sarcoma, Ewing
Start date
2021-04-02
Primary completion
2021-07-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.